NPI: 1821332339 · CROSSETT, AR 71635 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/21/2012
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/21/2012 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,963 | $122K |
| 2019 | 13,241 | $101K |
| 2020 | 11,571 | $83K |
| 2021 | 14,834 | $87K |
| 2022 | 9,099 | $61K |
| 2023 | 4,047 | $39K |
| 2024 | 1,611 | $19K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 28,460 | 1,359 | $128K |
| 82108 | 372 | 350 | $97K | |
| 83970 | 821 | 741 | $84K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 21,076 | 1,673 | $69K |
| 82728 | 485 | 460 | $41K | |
| A4657 | Syringe, with or without needle, each | 1,411 | 1,301 | $24K |
| 83550 | 518 | 493 | $15K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,409 | 742 | $15K |
| 83540 | 531 | 506 | $13K | |
| 85045 | 1,025 | 961 | $9K | |
| 85041 | 1,065 | 988 | $7K | |
| 85048 | 1,073 | 978 | $5K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 131 | 64 | $4K |
| J1756 | Injection, iron sucrose, 1 mg | 3,733 | 903 | $2K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 144 | 104 | $546.43 |
| G0008 | Administration of influenza virus vaccine | 82 | 73 | $210.88 |
| 90674 | 30 | 25 | $162.20 |